Cargando…
Nanoparticle Based Cardiac Specific Drug Delivery
SIMPLE SUMMARY: Heart disease is the leading cause of death, globally. Cardiomyocytes in adult mammalian hearts lose their capacity to divide. Therefore, the loss of heart muscles after a heart attack is usually irreversible. Many novel therapies that aim to repair injured myocardium have been repor...
Autores principales: | Li, Dong, Son, Yura, Jang, Michelle, Wang, Shu, Zhu, Wuqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856055/ https://www.ncbi.nlm.nih.gov/pubmed/36671774 http://dx.doi.org/10.3390/biology12010082 |
Ejemplares similares
-
Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease
por: Fan, Chengming, et al.
Publicado: (2020) -
Protein-Based Nanoparticles as Drug Delivery Systems
por: Hong, Seyoung, et al.
Publicado: (2020) -
Nanoparticles: Oral Delivery for Protein and Peptide Drugs
por: Cao, Shu-jun, et al.
Publicado: (2019) -
Silk Fibroin-Based Nanoparticles for Drug Delivery
por: Zhao, Zheng, et al.
Publicado: (2015) -
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
por: Kumari, Mamta, et al.
Publicado: (2023)